N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 18 USDMF, 19 CEP/COS, 1 JDMF, 7 EU WC, 3 KDMF, 12 NDC API, 35 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

309 FDF Dossiers, 48 FDA Orange Book, 208 Europe, 5 Canada, 14 South Africa, 34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 14 BASF, 1 BioSpectra, 1 Clariant, 6 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 15 Kerry, 2 Keval Exports, 12 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 15 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 31 Direct Compression, 29 Disintegrants & Superdisintegrants, 25 Granulation, 16 Thickeners and Stabilizers, 13 Co-Processed Excipients, 12 Lubricants & Glidants, 10 Solubilizers, 10 Chewable & Orodispersible Aids, 6 Controlled & Modified Release, 6 Parenteral, 5 Taste Masking, 4 Coating Systems & Additives, 3 Film Formers & Plasticizers, 3 Topical, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 6 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 27 Regulatory FDF Prices

MARKET PLACE

13 APIs, 12 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 11 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide

Filters

FILTER :

filter Company Reset all filters

22 All

01 22Kerry

filter Capability Reset all filters

filter Country Reset all filters

01

Kerry

DISINTEQUIK™ MCC 25

ICMD China

Not Confirmed

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Pharmaceutical Excipients offered by Kerry? Find N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide to address your drug delivery challenges on PharmaCompass.

N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers

18 USDMF

19 CEP/COS

1 JDMF

7 EU WC

3 KDMF

12 NDC API

35 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

309 FDF Dossiers

48 FDA Orange Book

208 Europe

5 Canada

14 South Africa

34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

8 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

1 Dr. Paul Lohmann GmbH & Co. KGaA

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

14 BASF

1 BioSpectra

1 Clariant

6 DFE Pharma

6 Gangwal Chemicals

1 Ideal Cures

3 Ingredion Pharma Solutions

15 Kerry

2 Keval Exports

12 Microlex e.U

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

4 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

15 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

2 Ulanqab Kema New Material

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders

31 Direct Compression

29 Disintegrants & Superdisintegrants

25 Granulation

16 Thickeners and Stabilizers

13 Co-Processed Excipients

12 Lubricants & Glidants

10 Solubilizers

10 Chewable & Orodispersible Aids

6 Controlled & Modified Release

6 Parenteral

5 Taste Masking

4 Coating Systems & Additives

3 Film Formers & Plasticizers

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons